Citations

Clear

16280 citation(s) found for "Yu, David".

Utilizing Spectral Counting To Quantitatively Characterize Tandem Removal of Abundant Proteins (TRAP) in Human Plasma
Shuford, Christopher M. , Hawkridge, Adam M. , Burnett, John C. , Muddiman, David C.

Mayo Clinic

Analytical Chemistry | November 19, 2010 | Volume: 82 | Issue: 24 | Pages: 10179-10185

10.1021/ac102248d | PMID 21090636 Get It

The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study
Andriole, Gerald L. , Bostwick, David G., Brawley, Otis W. , Gomella, Leonard G. , Marberger, Michael, Montorsi, Francesco , Pettaway, Curtis A. , Tammela, Teuvo L.J. , Telöken, Cláudio , Tindall, Donald J., Freedland, Stephen J. , Somerville, Matthew C. , Wilson, Timothy H., Fowler, Ivy L., Castro, Ramiro, Rittmaster, Roger S., Group, REDUCE Study, Larcher, Alessandro , Group, REDUCE Study

Mayo Clinic

Journal of Urology | November 13, 2010 | Volume: 185 | Issue: 1 | Pages: 126-131

10.1016/j.juro.2010.09.011 | PMID 21074214 Get It

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
Bordeleau, Louise , Pritchard, Kathleen I. , Loprinzi, Charles L. , Ennis, Marguerite , Jugovic, O., Warr, David, Haq, Rashida , Goodwin, Pamela J. , Ennis, Marguerite , Bordeleau, Louise

Mayo Clinic

Journal of Clinical Oncology | November 9, 2010 | Volume: 28 | Issue: 35 | Pages: 5147-5152

10.1200/jco.2010.29.9230 | PMID 21060031 Get It

Purpose Nonhormonal pharmacologic interventions are recommended for the treatment of hot flashes in breast cancer survivors. Antidepressants and gabapentin have been shown to be both effective and well tolerated; however, it is not clear which is preferred. Patients and Methods This was a group-sequential, open-label, randomized, cross-over trial of 4 weeks of venlafaxine (37.5 mg daily for 7 days followed by 75 mg daily for 21 days) versus gabapentin (300 mg once per day for 3 days, then 300 mg twice per day for 3 days, then 300 mg three times per day for 22 days), with patient preference as the primary outcome. Postmenopausal women with at least 14 bothersome hot flashes per week for the prior month were eligible. A 2-week baseline period and a 2-week tapering/washout time was used before the first and second treatment periods, respectively. Diaries were used to measure hot flashes and potential toxicities throughout the study. Participants completed a preference questionnaire at the end of the study. A predefined Pocock stopping rule was applied. Patient preference and hot flash and toxicity outcomes were compared between treatments. Results Sixty-six patients were randomly assigned, 56 of whom provided a preference (eight dropped out and two had no preference); 18 (32%) preferred gabapentin and 38 (68%) preferred venlafaxine (P = .01). Both agents reduced hot flash scores to a similar extent (66% reduction). Venlafaxine was associated with increased nausea, appetite loss, constipation, and reduced negative mood changes compared with gabapentin, whereas gabapentin was associated with increased dizziness and appetite compared with venlafaxine (all P < .05). Conclusion Breast cancer survivors prefer venlafaxine over gabapentin for treating hot flashes.
High normal fasting blood glucose is associated with dementia in Chinese elderly
Mortimer, James A., Borenstein, Amy R., Ding, Ding , DeCarli, Charles , Copenhaver, Cathleen, Guo, Qihao , Chu, Shugang, Salmon, David P. , Wu, Yougui , Petersen, Ronald C. , Hong, Zhen , Zhao, Qianhua , Galasko, Douglas , Dai, Qi , DeCarli, Charles

Mayo Clinic

Alzheimer's & Dementia | November 1, 2010 | Volume: 6 | Issue: 6 | Pages: 440-447

10.1016/j.jalz.2010.03.017 | PMID 21044774 Get It

BackgroundDiabetes is a risk factor for mild cognitive impairment (MCI) and dementia. However, the association between high normal fasting blood glucose (FBG) and dementia has not been studied.MethodsPolytomous logistic regression was used to assess the association of dementia and MCI with FBG in an age‐ and sex‐matched sample of 32 dementia patients, 27 amnestic MCI (aMCI) patients, and 31 normal controls (NC). Analyses were repeated for those with normal FBG. Correlations between FBG and cognitive test scores were obtained.ResultsControlling for age, gender, education, body mass index, Hachinski Ischemic Score, magnetic resonance imaging (MRI) stroke, and normalized brain, hippocampal, and white matter hyperintensity MRI volumes; higher FBG was associated with dementia versus aMCI status (OR = 3.13; 95% CI, 1.28–7.69). This association remained (OR = 7.75; 95% CI, 1.10–55.56) when analyses were restricted to subjects with normal FBG. When dementia patients were compared with NC adjusting for age, gender, and education, a significant association with FBG also was seen (OR = 1.83; 95% CI, 1.09–3.08), but it was lost when vascular covariates were added to the model. FBG was not associated with aMCI status versus NC. Higher FBG was correlated with poorer performance on the Trailmaking Test Part B (P = .003). The percentage of dementia patients with high normal FBG (90%) was significantly higher than that of aMCI patients with high normal FBG (32.9%) (χ2 = 13.9, P < .001).ConclusionsHigher FBG was associated with dementia (vs. aMCI) independent of vascular risk factors and MRI indicators of vascular disease, and remained a significant risk factor when analyses were restricted to subjects with normal FBG. The results of this cross‐sectional study suggest that a high normal level of FBG may be a risk factor for dementia.
Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis
Rasmussen‐Torvik, Laura J. , Li, Man , Kao, Wen H., Couper, David , Boerwinkle, Eric , Bielinski, Suzette J. , Folsom, Aaron R. , Pankow, James S. , Ballantyne, Christie M. , Bielinski, Suzette , Ballantyne, Christie M , Pankow, James S , Couper, David , Rasmussen-Torvik, Laura J

Mayo Clinic

Diabetes | October 30, 2010 | Volume: 60 | Issue: 1 | Pages: 331-335

10.2337/db10-0839 | PMID 21036910 Get It

OBJECTIVE Elevated fasting glucose level is associated with increased carotid intima-media thickness (IMT), a measure of subclinical atherosclerosis. It is unclear if this association is causal. Using the principle of Mendelian randomization, we sought to explore the causal association between circulating glucose and IMT by examining the association of a genetic risk score with IMT. RESEARCH DESIGN AND METHODS The sample was drawn from the Atherosclerosis Risk in Communities (ARIC) study and included 7,260 nondiabetic Caucasian individuals with IMT measurements and relevant genotyping. Components of the fasting glucose genetic risk score (FGGRS) were selected from a fasting glucose genome-wide association study in ARIC. The score was created by combining five single nucleotide polymorphisms (SNPs) (rs780094 [GCKR], rs560887 [G6PC2], rs4607517 [GCK], rs13266634 [SLC30A8], and rs10830963 [MTNR1B]) and weighting each SNP by its strength of association with fasting glucose. IMT was measured through bilateral carotid ultrasound. Mean IMT was regressed on the FGGRS and on the component SNPs, individually. RESULTS The FGGRS was significantly associated (P = 0.009) with mean IMT. The difference in IMT predicted by a 1 SD increment in the FGGRS (0.0048 mm) was not clinically relevant but was larger than would have been predicted based on observed associations between the FFGRS, fasting glucose, and IMT. Additional adjustment for baseline measured glucose in regression models attenuated the association by about one third. CONCLUSIONS The significant association of the FGGRS with IMT suggests a possible causal association of elevated fasting glucose with atherosclerosis, although it may be that these loci influence IMT through nonglucose pathways.
Summary of the Recommendations on Sexual Dysfunctions in Men
Montorsi, Francesco , Adaikan, Ganesan, Becher, Edgardo, Khoury, Saad, Lue, Tom F. , Sharlip, Ira D., Althof, Stanley E., Andersson, Karl-Eric, Brock, Gerald, Broderick, Gregory A. , Buvat, Jacques, Dean, John, Donatucci, Craig F., Eardley, Ian , Fugl-Meyer, Kerstin , Hackett, Geoff , Hatzichristou, Dimitris, Hellstrom, Wayne J.G. , Incrocci, Luca , Jackson, Graham, Levine, Laurence A. , Lewis, Ronald W., McCabe, Marita P. , McMahon, Chris G., Montague, Drogo K. , Montorsi, Piero, Mulhall, John P. , Pfaus, Jim, Porst, Hartmut, Ralph, David , Rosen, Raymond C., Sadeghi‐Nejad, Hossein , Shabsigh, Ridwan, Vardi, Yoram, Wallen, Kim , Wasserman, Marlene, Larcher, Alessandro , Giuliano, François , Burnett, Arthur L. “Bud” , Buvat, Jacques, Goldstein, Irwin , Kadıoğlu, Ateş , Maggi, Mario , Rowland, David L. , Stief, Christian G.

Mayo Clinic

The Journal of Sexual Medicine | October 29, 2010 | Volume: 7 | Issue: 11 | Pages: 3572-3588

10.1111/j.1743-6109.2010.02062.x | PMID 21040491 Get It

ABSTRACT Introduction Sexual health is an integral part of overall health. Sexual dysfunction can have a major impact on quality of life and psychosocial and emotional well-being. Aim To provide evidence-based, expert-opinion consensus guidelines for clinical management of sexual dysfunction in men. Methods An international consultation collaborating with major urologic and sexual medicine societies convened in Paris, July 2009. More than 190 multidisciplinary experts from 33 countries were assembled into 25 consultation committees. Committee members established scope and objectives for each chapter. Following an exhaustive review of available data and publications, committees developed evidence-based guidelines in each area. Main Outcome Measures New algorithms and guidelines for assessment and treatment of sexual dysfunctions were developed based on work of previous consultations and evidence from scientific literature published from 2003 to 2009. The Oxford system of evidence-based review was systematically applied. Expert opinion was based on systematic grading of medical literature, and cultural and ethical considerations. Results Algorithms, recommendations, and guidelines for sexual dysfunction in men are presented. These guidelines were developed in an evidence-based, patient-centered, multidisciplinary manner. It was felt that all sexual dysfunctions should be evaluated and managed following a uniform strategy, thus the International Consultation of Sexual Medicine (ICSM-5) developed a stepwise diagnostic and treatment algorithm for sexual dysfunction. The main goal of ICSM-5 is to unmask the underlying etiology and/or indicate appropriate treatment options according to men’s and women’s individual needs (patient-centered medicine) using the best available data from population-based research (evidence-based medicine). Specific evaluation, treatment guidelines, and algorithms were developed for every sexual dysfunction in men, including erectile dysfunction; disorders of libido, orgasm, and ejaculation; Peyronie’s disease; and priapism. Conclusions Sexual dysfunction in men represents a group of common medical conditions that need to be managed from a multidisciplinary perspective.
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Feldman, Andrew L. , Smith, David I., Ansell, Stephen M. , Johnson, Sarah H. , Porcher, Julie C., Özsan, Nazan , Wieben, Eric D. , Eckloff, Bruce W., Vasmatzis, George , Doǧan, Ahmet , Smith, David I., Law, Mark E. , Feldman, Andrew L

Mayo Clinic

Blood | October 29, 2010 | Volume: 117 | Issue: 3 | Pages: 915-919

10.1182/blood-2010-08-303305 | PMID 21030553 Get It

Abstract The genetics of peripheral T-cell lymphomas are poorly understood. The most well-characterized abnormalities are translocations involving ALK, occurring in approximately half of anaplastic large cell lymphomas (ALCLs). To gain insight into the genetics of ALCLs lacking ALK translocations, we combined mate-pair DNA library construction, massively parallel (“Next Generation”) sequencing, and a novel bioinformatic algorithm. We identified a balanced translocation disrupting the DUSP22 phosphatase gene on 6p25.3 and adjoining the FRA7H fragile site on 7q32.3 in a systemic ALK-negative ALCL. Using fluorescence in situ hybridization, we demonstrated that the t(6;7)(p25.3;q32.3) was recurrent in ALK-negative ALCLs. Furthermore, t(6;7)(p25.3;q32.3) was associated with down-regulation of DUSP22 and up-regulation of MIR29 microRNAs on 7q32.3. These findings represent the first recurrent translocation reported in ALK-negative ALCL and highlight the utility of massively parallel genomic sequencing to discover novel translocations in lymphoma and other cancers.
Untreated Type 2 Diabetes and Its Complications Are Associated With Subcortical Infarctions
Roberts, Rosebud O., Kantarci, Kejal , Geda, Yonas E. , Przybelski, Scott A. , Weigand, Stephen D. , Petersen, Ronald C. , Jack, Clifford R. , Knopman, David S. , Jack, Clifford R , Kantarci, Kejal , Geda, Yonas E

Mayo Clinic

Diabetes Care | October 28, 2010 | Volume: 34 | Issue: 1 | Pages: 184-186

10.2337/dc10-0602 | PMID 20980413 Get It

OBJECTIVE To investigate the association of type 2 diabetes with subcortical infarctions. RESEARCH DESIGN AND METHODS We investigated this association in subjects with type 2 diabetes (case subjects; n = 93) and without type 2 diabetes (control subjects; n = 186), matched by age, sex, and years of education. Participants were a subset of the Mayo Clinic Study of Aging (median age 79 years) who had undergone magnetic resonance imaging. RESULTS The frequency of subcortical infarctions was 39% in case subjects and 29% in control subjects (odds ratio 1.59 [95% CI 0.91–2.75]). The association was stronger in case subjects without treatment (2.60 [1.11–6.08]) and in case subjects with diabetes-related complications (1.96 [1.02–3.74]) compared with control subjects. CONCLUSIONS These findings suggest that untreated type 2 diabetes and type 2 diabetes with complications are associated with subcortical infarctions.
P4‐142: Contact Factors Differ for Dementia and Amnestic MCI in Chinese Elders: The Pilot SCOBHI Study.
Hong, Risk Zhen, Borenstein, Amy R., Mortimer, James A., Ding, Ding , Guo, Qihao , Salmon, David P. , Petersen, Ronald, Zhao, Qianhua , Galasko, Douglas

Mayo Clinic

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2010.08.201 Get It

P4‐126: Cognitive Performance Correlates with Resting State Connectivity and is Effected by APOE Status
Younkin, Steve, Petersen, Ronald C. , Jones, David T. , Machulda, Mary M. , McDade, Eric , Vemuri, Prashanthi , Zeng, Guang‐Zhi , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2010.08.185 Get It